Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways
{{output}}
Amyotrophic Lateral Sclerosis (ALS) is a progressive and disabling neurodegenerative disorder characterized by upper and lower motor neuron loss, leading to respiratory insufficiency and death after 3-5 years. Riluzole is currently the only FDA approved drug f... ...
